Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.

Clinical biochemistry·2018

Same author

Diagnostic yield of conventional transbronchial needle aspiration biopsy (C-TBNA) without an on-site cytopathologist: Experience of 363 procedures in 219 patients.

Tuberkuloz ve toraks·2016

Same author

Common variable immunodeficiency and pulmonary amyloidosis: a case report.

Journal of clinical immunology·2015

Same author

Peripapillary choroidal thickness in patients with chronic obstructive pulmonary disease.

Cutaneous and ocular toxicology·2015

Same author

Obstructive sleep apnea syndrome induced by laryngeal lesions: two cases.

Ear, nose, & throat journal·2013

Same author

Cigarette smoke and bleomycin-induced pulmonary oxidative stress in rats.

Experimental and therapeutic medicine·2012

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

Bronchial anthracofibrosis case with endobronchial tuberculosis.

Taha T Bekci¹, Emin Maden, Levent Emre

¹Department of Pulmonary Medicine, Konya Education and Research Hospital, Konya, Turkey. doktortaha@konyaea.gov.tr

International Journal of Medical Sciences

|January 15, 2011

Summary

This case study reveals a connection between bronchial anthracofibrosis and endobronchial tuberculosis. Visual and microbiological evidence supports this link, highlighting a potential correlation.

Keywords:

Anthracofibrosis endobronchial tuberculosis inflammatory bronchial stenosis

Related Experiment Videos

Last Updated: Jun 5, 2026

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration

Published on: November 10, 2014

Area of Science:

Pulmonology
Infectious Diseases
Pathology

Background:

Bronchial anthracofibrosis is a condition characterized by coal dust deposition in the airways.
Endobronchial tuberculosis involves tuberculosis affecting the bronchi.

Observation:

A unique case presented with co-existing bronchial anthracofibrosis and endobronchial tuberculosis.
The patient's clinical presentation suggested a potential link between these two conditions.

Findings:

Visual evidence confirmed the presence of anthracofibrosis within the bronchi.
Microbiological analysis identified Mycobacterium tuberculosis, confirming endobronchial tuberculosis.
The findings visually and microbiologically demonstrated a correlation between anthracofibrosis and endobronchial tuberculosis.

Implications:

This case suggests that bronchial anthracofibrosis may be a risk factor or co-morbidity for endobronchial tuberculosis.
Further research is warranted to explore the pathogenic mechanisms linking these conditions.
Understanding this correlation can inform diagnostic and treatment strategies for patients with airway anthracofibrosis.